We study the infrared cyclotron resonance of high-mobility monolayer graphene encapsulated in hexagonal boron nitride, and simultaneously observe several narrow resonance lines due to interband Landau-level transitions. By holding the magnetic field strength B constant while tuning the carrier density n, we find the transition energies show a pronounced nonmonotonic dependence on the Landau-level filling factor, ν∝n/B. This constitutes direct evidence that electron-electron interactions contribute to the Landau-level transition energies in graphene, beyond the single-particle picture. Additionally, a splitting occurs in transitions to or from the lowest Landau level, which is interpreted as a Dirac mass arising from coupling of the graphene and boron nitride lattices.
The cyclotron resonance of monolayer graphene, encapsulated in hexagonal boron nitride and with a graphite backgate, is explored via infrared transmission magnetospectroscopy as a function of the filling factor at fixed magnetic fields. The impact of many-particle interactions in the regime of broken spin and valley symmetries is observed spectroscopically. As the occupancy of the zeroth Landau level is increased from half-filling, a nonmonotonic progression of multiple cyclotron resonance peaks is seen for several interband transitions, revealing the evolution of underlying many-particle-enhanced gaps. Analysis of the peak energies shows significant exchange enhancements of spin gaps both at and below the Fermi energy, a strong filling-factor dependence of the substrate-induced Dirac mass, and also the smallest particle-hole asymmetry reported to date in graphene cyclotron resonance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.